Achieve life sciences appoints mark oki as chief financial officer

Seattle and vancouver, british columbia, dec. 09, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, today announced that mark oki has joined the company as its chief financial officer, effective december 5, 2024. mr. oki will oversee the company's financial strategy and operations, including accounting, investor relations, information technology, legal and other key administrative functions, ensuring effective planning and execution to support organizational objectives.
ACHV Ratings Summary
ACHV Quant Ranking